Breakthroughs in Alzheimer’s Disease Drug Development
International Journal of Biomedical Science · 2023
DOI: 10.59566/iabs.2023.p008 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biomedical Science, 2023. Verfasst von Jing Liang.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative condition characterized by cognitive decline and memory loss. The current lack of understanding regarding the cause of AD has impeded the development of animal models for drug testing, resulting in a dearth of effective prevention and treatment methods. Despite efforts to target Aβ plaques and tau protein tangles, which have proven ineffective, it is evident that these factors alone do not fully account for the cognitive deficits and memory loss associated with AD. While clinical trials seek effective treatments, success remains uncertain.
Zitieren
APA
Liang, J. (2023). Breakthroughs in Alzheimer’s Disease Drug Development. International Journal of Biomedical Science. https://doi.org/10.59566/iabs.2023.p008
Vancouver
Liang J. Breakthroughs in Alzheimer’s Disease Drug Development. International Journal of Biomedical Science. 2023. doi:10.59566/iabs.2023.p008
BibTeX
@article{Liang2023,
author = {Liang, Jing},
title = {Breakthroughs in Alzheimer’s Disease Drug Development},
journal = {International Journal of Biomedical Science},
year = {2023},
doi = {10.59566/iabs.2023.p008}
}
EUVIMED